Is the price fair?
What STE's price assumes
STERIS plc trades at 29.9× earnings against 33.4× for the median Medical Devices name, cheaper than its own group.
29.9
Trailing P/E · Medical Devices median 33.4 · cheaper than the typical name in its group
- Price / sales
- 3.63
Price / sales · as of 2026-Q1
- Free cash flow yield
- 4.9%
Free cash flow yield · Medical Devices median 4.0%
- Growth the price implies
- +5.9%
Growth the price implies · The price pays for +5.9% free cash flow growth a year for a decade; the business has delivered +35% a year over the last three.
Details›
- Price / book2026-Q1
- 3.00
- EV / EBIT2026-Q1
- 20.8
- EV / sales2026-Q1
- 3.86
- Healthcare median P/E362 names
- 31.5
- Medical Devices median P/E39 names
- 33.4
- Free cash flow, trailing twelve months
- $972M
- Market capitalisation
- $19.7B
- 3-year revenue growth
- +9.4%
- 3-year free cash flow growth
- +35%
| Method | Per share |
|---|---|
| Its own P/E history, lower quartile | $273.67 |
| Its own P/E history, median | $354.57 |
| Its own P/E history, upper quartile | $433.80 |
| 52-week range | $199.40 – $267.17 |
| Today | $236.86 |
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Medical Devices
Ranks #13 of 35 by Smart Score